Smoking cessation
🟢 Quitting smoking before conception lowers maternal cardiovascular strain, which is already elevated in clients with chronic hypertension.
🟢 Tobacco exposure is linked to placental insufficiency, fetal growth restriction, preterm birth, and higher rates of perinatal morbidity—all risks magnified in hypertensive pregnancies.
🟢 Stopping smoking improves endothelial function within weeks and supports better blood pressure control prior to conception.
🟢 Evidence‑based counseling plus behavioral support is first line; NRT may be considered if non‑pharmacologic methods fail after risk–benefit discussion.
🟢 Integrating cessation into the preconception plan reduces preeclampsia, abruption, and low‑birth‑weight risk, improving maternal–fetal outcomes.
Assessment of dietary habits
🟢 Reviewing nutrition identifies modifiable risks like excess sodium, which worsens fluid retention and hypertension in pregnancy.
🟢 A DASH‑style pattern rich in fruits, vegetables, whole grains, and low‑fat dairy supports lower BP and healthier weight before conception.
🟢 Setting targets such as <2.3 g sodium/day (often 1.5 g if tolerated) and adequate potassium (unless CKD) improves baseline control.
🟢 Counseling includes weight optimization, limiting alcohol, and moderating caffeine, all of which influence BP and fertility.
🟢 Early diet changes help achieve a safer pre‑pregnancy BMI and reduce the risk of hypertensive complications once pregnant.
Evaluation of comorbidities
🟢 A thorough review for diabetes, chronic kidney disease, dyslipidemia, OSA, and secondary hypertension guides risk stratification before conception.
🟢 Baseline studies (e.g., serum creatinine/eGFR, urinalysis & protein/albumin‑to‑creatinine ratio, A1c, electrolytes, and ECG/echo when indicated) document end‑organ status.
🟢 Medication reconciliation is essential—transition teratogenic agents (e.g., ACE inhibitors, ARBs, renin inhibitors, spironolactone) to pregnancy‑preferred drugs (labetalol, nifedipine ER, methyldopa).
🟢 Optimizing comorbidities lowers risks of preeclampsia, fetal growth restriction, preterm birth, and maternal cardiovascular events.
🟢 Planning for low‑dose aspirin initiation in early pregnancy (commonly 12–16 weeks for high‑risk patients) is facilitated by this preconception evaluation.
Pre‑pregnancy immunization
🟢 Updating immunizations reduces maternal infections that can destabilize blood pressure and threaten fetal health.
🟢 Live vaccines (e.g., MMR, varicella) should be given before pregnancy with adequate intervals to conception to ensure immunity.
🟢 Influenza (in season) and COVID‑19 vaccines decrease severe maternal illness, which can precipitate hypertensive crises and obstetric complications.
🟢 Ensure hepatitis B vaccination for at‑risk clients; Tdap is planned during pregnancy, but verifying status preconception streamlines care.
🟢 Immunization review during counseling integrates with overall risk reduction, safeguarding both maternal and neonatal outcomes.